{
  "DOI": "10.1007/s10689-018-0104-4",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-018-0104-4",
  "alternative-id": [
    "104"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "24 September 2018"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Bettina Meiser has a remunerated consultant role with the company Astrazeneca with respect to an unrelated project."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-4406-4327",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kaur",
      "given": "Rajneesh",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Meiser",
      "given": "Bettina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yanes",
      "given": "Tatiane",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Young",
      "given": "Mary-Anne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Barlow-Stewart",
      "given": "Kristine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roscioli",
      "given": "Tony",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Smith",
      "given": "Sian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "James",
      "given": "Paul A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        9,
        24
      ]
    ],
    "date-time": "2018-09-24T16:02:20Z",
    "timestamp": 1537804940000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        9,
        5
      ]
    ],
    "date-time": "2023-09-05T10:22:38Z",
    "timestamp": 1693909358000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000925",
      "award": [
        "1023698"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Health and Medical Research Council"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        22
      ]
    ],
    "date-time": "2024-02-22T10:43:44Z",
    "timestamp": 1708598624141
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2018,
        9,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2019,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            9,
            24
          ]
        ],
        "date-time": "2018-09-24T00:00:00Z",
        "timestamp": 1537747200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-0104-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-018-0104-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-0104-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "147-152",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2018,
        9,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        9,
        24
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(01)06524-2",
      "author": "Collaborative Group on Hormonal Factors in Breast Cancer",
      "doi-asserted-by": "publisher",
      "first-page": "1389",
      "issue": "9291",
      "journal-title": "Lancet",
      "key": "104_CR1",
      "unstructured": "Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399",
      "volume": "358",
      "year": "2001"
    },
    {
      "DOI": "10.1001/jama.2010.1237",
      "author": "S Domchek",
      "doi-asserted-by": "publisher",
      "first-page": "967",
      "issue": "9",
      "journal-title": "J Amer Med Assoc",
      "key": "104_CR2",
      "unstructured": "Domchek S, Friebel T, Singer C (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. J Amer Med Assoc 304(9):967–975",
      "volume": "304",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2008.20.5179",
      "author": "K Visvanathan",
      "doi-asserted-by": "publisher",
      "first-page": "3235",
      "issue": "19",
      "journal-title": "J Clin Oncol",
      "key": "104_CR3",
      "unstructured": "Visvanathan K et al (2009) American Society of Clinical Oncology clinical practice guideline update on the use of pharmacological interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol 27(19):3235–3258",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1093/jnci/djn442",
      "author": "T Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "journal-title": "J Natl Cancer Inst",
      "key": "104_CR4",
      "unstructured": "Rebbeck T, Kauff N, Domchek S (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87",
      "volume": "101",
      "year": "2009"
    },
    {
      "DOI": "10.1023/B:JOMG.0000048770.90334.3b",
      "author": "D Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "issue": "3",
      "journal-title": "J Mammary Gland Biol Neoplasia",
      "key": "104_CR5",
      "unstructured": "Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9(3):221–236",
      "volume": "9",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10897-011-9462-x",
      "author": "BD Riley",
      "doi-asserted-by": "publisher",
      "first-page": "151",
      "issue": "2",
      "journal-title": "J Genet Couns",
      "key": "104_CR6",
      "unstructured": "Riley BD et al (2012) Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 21(2):151–161",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2012.41.7469",
      "author": "S Sawyer",
      "doi-asserted-by": "publisher",
      "first-page": "4330",
      "issue": "35",
      "journal-title": "J Clin Oncol",
      "key": "104_CR7",
      "unstructured": "Sawyer S et al (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30(35):4330–4336",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-016-3897-6",
      "author": "TA Muranen",
      "doi-asserted-by": "publisher",
      "first-page": "463",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "104_CR8",
      "unstructured": "Muranen TA et al (2016) Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families. Breast Cancer Res Treat 158(3):463–469",
      "volume": "158",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature24284",
      "author": "K Michailidou",
      "doi-asserted-by": "publisher",
      "first-page": "92",
      "issue": "7678",
      "journal-title": "Nature",
      "key": "104_CR9",
      "unstructured": "Michailidou K et al (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551(7678):92–94",
      "volume": "551",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ng.3242",
      "author": "K Michailidou",
      "doi-asserted-by": "publisher",
      "first-page": "373",
      "issue": "4",
      "journal-title": "Nat Genet",
      "key": "104_CR10",
      "unstructured": "Michailidou K et al (2015) Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet 47(4):373–380",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.2563",
      "author": "K Michailidou",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "issue": "4",
      "journal-title": "Nat Genet",
      "key": "104_CR11",
      "unstructured": "Michailidou K et al (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45(4):353–361, 361e1–361e2",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1093/jnci/djv036",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "5",
      "journal-title": "J Natl Cancer Inst",
      "key": "104_CR12",
      "unstructured": "Mavaddat N et al (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 107(5):1–15",
      "volume": "107",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jama.2017.7112",
      "author": "KB Kuchenbaecker",
      "doi-asserted-by": "publisher",
      "first-page": "2402",
      "issue": "23",
      "journal-title": "JAMA",
      "key": "104_CR13",
      "unstructured": "Kuchenbaecker KB et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416",
      "volume": "317",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2016.43",
      "author": "H Li",
      "doi-asserted-by": "publisher",
      "first-page": "30",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "104_CR14",
      "unstructured": "Li H et al (2017) Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab. Genet Med 19(1):30–35",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-15-0838",
      "author": "GS Dite",
      "doi-asserted-by": "publisher",
      "first-page": "359",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "104_CR15",
      "unstructured": "Dite GS et al (2016) Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian breast cancer family registry. Cancer Epidemiol Biomark Prev 25:359–365",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s12885-017-3485-0",
      "author": "T Yanes",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "104_CR16",
      "unstructured": "Yanes T et al (2017) Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study. BMC Cancer 17(1):491",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1093/her/cyg123",
      "author": "R Clerehan",
      "doi-asserted-by": "publisher",
      "first-page": "334",
      "issue": "3",
      "journal-title": "Health Educ Res",
      "key": "104_CR17",
      "unstructured": "Clerehan R, Buchbinder R, Moodie J (2005) A linguistic framework for assessing the quality of written patient information: its use in assessing methotrexate information for rheumatoid arthritis. Health Educ Res 20(3):334–344",
      "volume": "20",
      "year": "2005"
    },
    {
      "DOI": "10.1558/cam.v6i2.117",
      "author": "R Clerehan",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "issue": "2",
      "journal-title": "Commun Med",
      "key": "104_CR18",
      "unstructured": "Clerehan R, Hirsh D, Buchbinder R (2009) Medication information leaflets for patients: the further validation of an analytic linguistic framework. Commun Med 6(2):117–127",
      "volume": "6",
      "year": "2009"
    },
    {
      "key": "104_CR19",
      "unstructured": "Flesch-Kincaid readability score. Readability Scores: Flesch-Kincaid readability score (2018) http://www.rfp-templates.com/Readability-Scores/Flesch-Kincaid"
    },
    {
      "DOI": "10.1002/pon.1353",
      "author": "CE Wakefield",
      "doi-asserted-by": "publisher",
      "first-page": "844",
      "issue": "8",
      "journal-title": "Psychooncology",
      "key": "104_CR20",
      "unstructured": "Wakefield CE et al (2008) A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psychooncology 17(8):844–854",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10897-006-9068-x",
      "author": "CE Wakefield",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "104_CR21",
      "unstructured": "Wakefield CE et al (2007) Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. J Genet Couns 16(3):325–339",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.pec.2010.05.025",
      "author": "CE Wakefield",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "issue": "1",
      "journal-title": "Patient Educ Couns",
      "key": "104_CR22",
      "unstructured": "Wakefield CE et al (2011) Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer. Patient Educ Couns 83(1):64–72",
      "volume": "83",
      "year": "2011"
    },
    {
      "DOI": "10.1093/pubmed/23.3.227",
      "author": "CJ McPherson",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "issue": "3",
      "journal-title": "J Public Health Med",
      "key": "104_CR23",
      "unstructured": "McPherson CJ, Higginson IJ, Hearn J (2001) Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med 23(3):227–234",
      "volume": "23",
      "year": "2001"
    },
    {
      "DOI": "10.1002/pon.1081",
      "author": "A Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "458",
      "issue": "5",
      "journal-title": "Psychooncology",
      "key": "104_CR24",
      "unstructured": "Metcalfe A et al (2007) Psychosocial impact of the lack of information given at referral about familial risk for cancer. Psychooncology 16(5):458–465",
      "volume": "16",
      "year": "2007"
    }
  ],
  "reference-count": 24,
  "references-count": 24,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-018-0104-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}